76 results
Page 2 of 4
8-K
EX-4.1
0et8u yfen8vk
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
8-K
EX-1.1
znkrp366t5
22 Aug 22
UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering
4:13pm
424B5
rfytmtgegklno a6xml
19 Aug 22
Prospectus supplement for primary offering
8:42am
424B5
z8o84w
19 Aug 22
Prospectus supplement for primary offering
8:37am
424B5
wammg n392g
16 Aug 22
Prospectus supplement for primary offering
5:26pm
8-K
EX-99.2
v0ki5pi2syxj r8sa5wa
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
8-K
EX-99.1
l8o8gx9r5984rxz2zfan
12 Aug 22
UNITY Biotechnology Announces Positive Data in Phase 2 BEHOLD Study of UBX1325 in Patients with Diabetic Macular Edema
7:18am
424B5
umtqqccd0wu0hcoeqd5f
13 May 22
Prospectus supplement for primary offering
4:18pm
PRE 14A
mto2 iwx0ykk1sr6g5
12 Apr 22
Preliminary proxy
4:02pm
8-K
EX-10.1
thl0qiiikpnm7hhoh
29 Sep 21
Entry into a Material Definitive Agreement
5:26pm
424B5
1i91 ydx7
29 Sep 21
Prospectus supplement for primary offering
5:24pm
8-K
EX-99.1
vhtfa6hjr24pk18sy1sz
10 Aug 21
UNITY Biotechnology, Inc. Reports Second Quarter 2021 Financial Results and Business Updates
4:05pm